Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries

Effective and durable options for infrapopliteal artery revascularization for patients with chronic limb-threatening ischemia (CLTI) are limited. The SAVAL trial is a prospective, multicenter, randomized trial of patients with CLTI and infrapopliteal artery lesions with total lesion length ⩽ 140 mm,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vascular medicine (London, England) Jg. 28; H. 6; S. 571
Hauptverfasser:	van Overhagen, Hans, Nakamura, Masato, Geraghty, Patrick J, Rao, Sid, Arroyo, Max, Soga, Yoshimitsu, Iida, Osamu, Armstrong, Ehrin, Nakama, Tatsuya, Fujihara, Masahiko, Ansari, Mohammad M, Mathews, Santhosh J, Gouëffic, Yann, Jaff, Michael R, Weinberg, Ido, Pinto, Duane S, Ohura, Norihiko, Couch, Kara, Mustapha, Jihad A
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 01.12.2023
Schlagworte:	Angioplasty, Balloon - adverse effects Drug-Eluting Stents - adverse effects Humans Ischemia - diagnostic imaging Ischemia - therapy Paclitaxel - adverse effects Peripheral Arterial Disease - diagnostic imaging Peripheral Arterial Disease - therapy Popliteal Artery - diagnostic imaging Prospective Studies Stents Treatment Outcome Vascular Patency stent chronic limb-threatening ischemia (CLTI) endovascular therapy peripheral artery disease (PAD)
ISSN:	1477-0377, 1477-0377
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!